Business Wire

Regula Hits NIST Test: The Only Vendor Recognized Among Top Performers in All Critical Age Estimation Scenarios

9.9.2025 14:30:00 CEST | Business Wire | Press release

Share

For the first time, Regula, a global developer of identity verification (IDV) solutions and forensic devices, has taken part in the National Institute of Standards and Technology (NIST) evaluation for age estimation. This debut could hardly be stronger: Regula achieved the best result in the test, outperforming other vendors. Crucially, Regula’s technology demonstrated consistent accuracy across a wide range of demographics, making it the most universal solution on the market.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909879354/en/

Regula’s technology estimates age with unmatched precision, gaining top results in the independent NIST test

In addition, Regula ranked among the top three in two of the most critical age assurance scenarios: Challenge 25 and Child Online Safety (ages 13–16).

NIST is a globally respected authority in technology testing and standardization. Its Face Analysis Technology Evaluation (FATE) Age Estimation and Verification benchmark is an open, ongoing program that evaluates how software algorithms estimate age from facial photos. This capability is increasingly important nowadays, as regulators worldwide require reliable age checks to protect minors, enforce access restrictions, and confirm an individual’s age in the absence of official documents.

In this evaluation, NIST confirmed that Regula’s technology estimates age with exceptional accuracy across demographies, consistently outperforming other tested solutions. It came closer to the true age than any other solution tested so far. Regula’s algorithm delivered top results worldwide, with consistent leading accuracy across Europe, East Africa, and East and South Asia.

Beyond overall precision, Regula also excelled in age-restricted scenarios that are directly relevant to regulators and businesses. The Challenge 25 benchmark measures whether individuals who are close to 17 are reliably flagged for additional checks to prevent underage sales. The Child Online Safety benchmark focuses on accurately detecting users aged 13–16 in online environments, while minimizing misclassifications of younger children or adults. Achieving a top-three rank in both scenarios demonstrates that Regula’s technology not only excels in estimating real age but also in protecting minors and helping organizations comply with some of the toughest age-assurance requirements.

The age assurance enhancement will be included in the upcoming Regula Face SDK update. Designed for robust biometric verification, this solution enables thorough facial recognition and comparison, liveness detection, and age verification—an indispensable set of checks to prove that an individual is legitimate and real.

“Reaching the highest accuracy in the NIST evaluation proves the strength of our forensic-driven approach and biometric verification expertise. Just as important, the results confirm that Regula performs consistently across a wide range of real-world conditions, making our solution the most universal on the market. And we’re not stopping here: we are already working to make the technology even more precise and inclusive. Incorporating it into Regula Face SDK will equip our customers with a powerful, reliable way to estimate age in the most challenging environments," says Ihar Kliashchou, Chief Technology Officer at Regula.

Earlier this year, Regula was also recognized as a pioneer in online biometric age assurance for its comprehensive approach that combines advanced document verification with biometric authentication.

For more details on the NIST evaluation of age estimation technologies, see the official report. To learn what challenges and capabilities form today’s age verification solutions, please visit Regula’s website.

About Regula

Regula is a global developer of forensic devices and identity verification solutions. With our 30+ years of experience in forensic research and the most comprehensive library of document templates in the world, we create breakthrough technologies for document and biometric verification. Our hardware and software solutions allow over 1,000 organizations and 80 border control authorities globally to provide top-notch client service without compromising safety, security, or speed. Regula has been repeatedly named a Representative Vendor in the Gartner® Market Guide for Identity Verification.

Learn more at www.regulaforensics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250909879354/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex to Present New Data on ALYFTREK® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press release

- Data on ALYFTREK in children ages 2 to 5 years demonstrate recovery of pancreatic function in some children –- Additional abstracts on clinical and real-world evidence on CFTR modulators also presented - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine p

Andersen Consulting udvider med TalentSmartEQ for at fremme lederskab og virksomhedstransformation9.10.2026 18:48:00 CEST | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for humankapital gennem en samarbejdsaftale med TalentSmartEQ, en San Diego-baseret virksomhed, der har fokus på at skabe praktiske, engagerende og handlingsorienterede læringsoplevelser med udgangspunkt i emotionel intelligens (EQ) og lederudvikling. I mere end to årtier har TalentSmartEQ arbejdet sammen med organisationer verden over med henblik på at udvikle ledelseskompetencer ved hjælp af emotionel intelligens og dermed styrke medarbejderengagement, teamwork og de samlede resultater. Virksomheden kombinerer forskningsbaserede metoder med praktiske læringsforløb, vurderinger, coaching og skræddersyede programmer, der skal omsætte opbygningen af emotionel intelligens til vedvarende ændringer i adfærden på arbejdspladsen. Som førende aktør i branchen samarbejder TalentSmartEQ med organisationer lige fra Fortune 500-virksomheder til offentlige myndigheder og privatejede virksomheder. "Organisationer stiller stadig større krav til dere

Verdant Rock Receives A (low) Financial Strength Rating from Morningstar DBRS, Adding a Second International Investment-Grade Assessment9.10.2026 16:00:00 CEST | Press release

Verdant Rock now holds Financial Strength Ratings from both Fitch Ratings and Morningstar DBRS, providing counterparties with dual-agency confirmation and reinforcing the security architecture behind each financial guarantee Verdant Rock Limited, a Bermuda Monetary Authority-regulated Class 3B insurance company, has received an A (low) Financial Strength Rating from Morningstar DBRS. The rating reflects Verdant Rock’s financial strength and its capacity to meet policyholder obligations as an investment-grade financial guarantor for Emerging Markets credit. Morningstar DBRS is a global credit rating agency with coverage across North America, Europe, Asia, and Latin America. Its assessment of Verdant Rock reflects the company’s strong projected earnings ability, robust risk profile, sound liquidity, and good capitalization. Morningstar DBRS also assigned an A (low) Issuer Rating to Verdant Rock. The rating follows Verdant Rock’s BBB+ Long-Term Insurer Financial Strength Rating with a Sta

Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions9.10.2026 15:17:00 CEST | Press release

We think Gartner recognizes Tecnotree's open, governed approach to agentic AI as operators make AI the engine of their revenue operations Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, today announced that Gartner has positioned it as a Visionary in the first-ever Magic Quadrant for AI-Enabled CSP Marketing and Sales Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261009905430/en/ Tecnotree Named a Visionary in the Inaugural 2026 Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions A new category for a new operating model. CSPs are fighting saturated markets, rising acquisition costs, and accelerating churn. They are responding with AI-driven automation across the full revenue cycle, from segmentation and campaigns to lead management, CPQ, and renewals, increasingly executed by autonomous agents. According to us, Gartner creation of this Magi

Positive New Data on Corcym’s Perceval Plus Sutureless Aortic Heart Valve Encompasses up to 7-Year Follow-up9.10.2026 15:15:00 CEST | Press release

Data Presented at Annual Meeting of European Association for Cardio-Thoracic Surgery (EACTS), Along with 6 Perceval Plus E-PostersEACTS Also Marks Commercial Launch of TriMemo and Memo 4D Curve, Innovative Repair Devices for Tricuspid and Mitral Valves Corcym, a global medical device company dedicated to cardiac surgery, today announced that positive mid-term data from a sub-analysis of its Perceval Plus sutureless aortic heart valve as part of its MANTRA clinical trial was featured in an oral presentation today at the annual meeting of the European Association for Cardio-Thoracic Surgery (EACTS). The study is the longest follow-up available for Perceval Plus and the FREE tissue treatment from an international multicenter study, and demonstrated excellent durability, safety and quality of life improvements. Perceval Plus is the only sutureless and collapsible aortic surgical heart valve. Its unique design performs in any surgical scenario and is optimal for endoscopy and robotics. The

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye